Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of October 14, 2026, NEPH trades at $3.50 with a market cap of $38.77M and a P/E ratio of 29.27. NEPH moved -0.28% today. Year to date, NEPH is -24.42%; over the trailing twelve months it is -32.77%. Its 52-week range spans $1.39 to $6.42. Analyst consensus is buy with an average price target of $6.38. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover NEPH: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $6.38.
| Metric | Value |
|---|---|
| Price | $3.50 |
| Market Cap | $38.77M |
| P/E Ratio | 29.27 |
| EPS | $0.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.42 |
| 52-Week Low | $1.39 |
| Volume | 20.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $18.79M |
| Net Income | $1.19M |
| Gross Margin | 61.87% |
2 analysts cover NEPH: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.38.